Access
To read this story in full you will need to login or make a payment (see right).
Technology Feature
Nature 450, 1117 (13 December 2007) | doi:10.1038/4501117b; Published online 12 December 2007
nature jobs
Post-Doctoral Position BAT IIa
- Justus-Liebig-University Giessen
- Giessen 35390 Germany
Postdoctoral Research Fellow ? Andy Chan?s Lab / Immunology
- Genentech
- South San Francisco, CA, USA
Small RNAs: The Vehicle Laboratory
Many companies are realizing that the development of new delivery vehicles for therapeutics based on RNA interference (RNAi) will require collaborative efforts. "We view the delivery of small RNAs as one of the most important biomedical endeavours in modern biological science," says John Maraganore, chief executive of Alnylam Pharmaceuticals in Cambridge, Massachusetts.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Drug delivery Old polymer learns new tractsNature Materials News and Views (01 Jun 2009)
